PHK
ARCT icon

Point72 Hong Kong’s Arcturus Therapeutics ARCT Stock Holding History

Point72 Hong Kong’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,493
Closed -$102K – 1914
2022
Q2 		$102K Buy
6,493
+6,320
+3,653% +$124K ﹤0.01% 1178
2022
Q1 		$5K Buy
+173
New +$4.42K ﹤0.01% 1673
2021
Q4 		– Sell
-2,422
Closed -$116K – 1867
2021
Q3 		$116K Buy
+2,422
New +$109K ﹤0.01% 1307
2021
Q2 		– Sell
-461
Closed -$19K – 1901
2021
Q1 		$19K Buy
+461
New +$27.5K ﹤0.01% 1481
2020
Q4 		– Sell
-2,281
Closed -$98K – 1701
2020
Q3 		$98K Buy
2,281
+2,266
+15,107% +$112K 0.01% 563
2020
Q2 		$1K Buy
+15
New +$517 ﹤0.01% 1088

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Point72 Hong Kong's ARCT Position: Q3 2022 in Review

Point72 Hong Kong sold out of Arcturus Therapeutics (ARCT) in Q3 2022, closing a stake of 6,493 shares — an estimated $102K sold.

Point72 Hong Kong first reported a position in ARCT in Q2 2020 and held it in 6 quarters. The position peaked at $116K in Q3 2021. 116 funds tracked by Wall St. Rank hold ARCT as of Q3 2022.

  • Point72 Hong Kong reported no remaining Arcturus Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 6,493 Arcturus Therapeutics shares in Q3 2022, an estimated $102K.
  • Point72 Hong Kong first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 6 quarters.
  • Point72 Hong Kong's Arcturus Therapeutics position peaked at $116K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.